Human platelet antigen genotyping of platelet donors at a transfusion center in northern Pakistan

Authors

  • Sidra Aslam Army Medical College (National University of Medical Sciences), Rawalpindi Pakistan/ Mohtarma Benazir Bhutto Shaheed Medical College, Mirpur Azad Jammu Kashmir
  • Nuzhat Salamat Armed Forces Institute of Transfusion (National University of Medical Sciences), Rawalpindi Pakistan
  • Nasiruddin Army Medical College (National University of Medical Sciences), Rawalpindi Pakistan/ Mohtarma Benazir Bhutto Shaheed Medical College, Mirpur Azad Jammu Kashmir
  • Sajid Yazdani Armed Forces Institute of Transfusion (National University of Medical Sciences), Rawalpindi Pakistan
  • Saleem Ahmad Khan Army Medical College (National University of Medical Sciences), Rawalpindi Pakistan/ Mohtarma Benazir Bhutto Shaheed Medical College, Mirpur Azad Jammu Kashmir
  • Abdul Naeem Armed Forces Institute of Transfusion (National University of Medical Sciences), Rawalpindi Pakistan

DOI:

https://doi.org/10.55629/pakjpathol.v35i4.860

Abstract

Objective: The study aimed to specify the allele frequency of Human platelet antigen (HPA-1 to HPA-5 and HPA-15) platelets in blood donors at a transfusion center in Northern Pakistan.
Material and Methods: This cross-sectional analytical study was conducted at Armed Forces Institute of Transfusion (National University of Medical Sciences) Rawalpindi from 1 January to 31 December 2021. We executed HPA genotyping of 384 healthy, inapplicable platelet and whole blood donors by polymerase chain reaction with sequence-specific primers for 06 biallelic systems (HPA-1 to -5 and -15) that have been associated with platelet antigen alloimmunization.

Results: The allele frequency of HPA-1a/1b, -2a/2b, -3a/3b, -4a/4b, -5a/5b, and -15a/15b in this population is 0.91/0.09, 0.92/0.08, 0.72/0.28, 1/0, 0.89/0.11, 0.58/0.42 respectively. The mismatch probability percentage of platelet antigens HPA-1 to -5 and -15 ranges from 13.8 to 36%, and the incompatibility risk is highest for HPA-15. HPA-1b, -2b, -4b, and -5b homozygosity is 0.5%, 0.5%, 0 and 7.8%, while homozygosity of HPA-3b and -15b is 13.8% and 28.6%, respectively.
Conclusion: Polymerase chain reaction with sequence-specific primer (PCR-SSP) is a valid method for HPA screening in blood donors. Evaluating HPA in our region may be an initial step towards devising a registry of platelet donors and foreshadowing platelet alloimmunization and treatment in our territory.

Keywords: Allele frequency, Alloimmunization, Genotypes, Human platelet antigens (HPA), Mismatch probability, PCR-SSP, Real-time polymerase chain reaction

References

Kiefel V. Platelet antibodies in immune thrombocytopenia and related conditions. J Lab Med. 2020; 44(5): 273-84.

DOI: https://doi.org/10.1515/labmed-2020-0012

Zhang J, Yuan W, Hong X, Ying Y, Zhu F. Simultaneous high throughput genotyping of 36 blood group systems using NGS based on probe capture technology. Heliyon. 2024; 10(13): e33608. DOI:https://doi.org/10.1016/j.heliyon.2024.e33608

Nozarimirarkolaei M, Dadashi M, Ghasemi A, Samiee S, Shaeigan M, Zadsar M. Frequency of human platelet antigens− 1 to− 5 and− 15 in Turkmen blood donors. Adv Biomed Res. 2023; 12(1): 47.

DOI: https://doi.org/10.4103/abr.abr_282_21

Santos LA, de Almeida AC, Tarragô AM, da Silva NR, da Silva JN, de Souza MM, et al. Investigation of delayed transfusion reactions in sickle cell disease patients poly transfused in the Brazilian Amazon. Hematol Rep. 2024;16(3): 512-22. DOI: https://doi.org/10.3390/hematolrep16030049

Ukonu UC, Nwosu DC, Okoroiwu LI, Dike-Ndudim JN, Ukonu GO, Obeagu EI. Evaluation of Alloantibodies to human platelet antigen and Leucocyte antigen class 1 in Multitransfused patients in Owerri, Imo state. Int J Curr Res Med Sci. 2023; 9(1): 38-44. DOI: http://dx.doi.org/10.22192/ijcrms.2023.09.01 .005

Rophina M, Bhoyar RC, Imran M, Senthivel V, Divakar MK, Mishra A, et al. Genetic variants of human platelet antigens in the Indian population from 1029 whole genomes. Int J Immunogenet. 2023; 50(3): 134-43.

DOI: https://doi.org/10.1111/iji.12622

Kazemi MH, Malakootikhah F, Momeni-Varposhti Z, Falak R, Delbandi AA, Tajik N. Human platelet antigen 1-6, 9 and 15 in the Iranian population: An anthropological genetic analysis. Sci Rep. 2020; 10(1): 7442.

DOI: https://doi.org/10.1038/s41598-020-64469-4

Shaiegan M, Ghasemi A, Madani T, Samiee S, Bayat B, Mohammadi S, et al. Gene frequencies of human platelet antigen‐1 to‐5 and‐15 in the Iranian population. ISBT Sci Series. 2020; 15(2): 273-80. DOI: https://doi.org/10.1111/voxs.12532

Azizi SG, Samiee S, Zadsar M, Shaiegan M. Validating the HPA-1 to-5 and-15 detection by homemade PCR-SSP, Real-Time PCR, and PCR-RFLP methods. Lab Med. 2022; 53(6): 570-9.

DOI: https://doi.org/10.1093/labmed/lmac050

Blanco S, Frutos MC, Carrizo LH, Nogués N, Gallego SV. Establishment of the first platelet-donor registry in Argentina. Blood Transfus. 2020; 18(4): 254-60. DOI: https://doi.org/10.2450/2020.0018-20

Ullah I, Arshad A, Waheed U, e Saba N, Qasim Z, Arshad M. Genotyping of platelet alloantigens by DNA sequencing in Pakistani population. J Islamabad Med Dental Coll. 2023; 12(2): 71-81.

DOI: https://doi.org/10.35787/jimdc.v12i2.981

Ghaffari K, Rad MA, Moradi Hasan-Abad A, Khosravi M, Benvidi A, Iraji M, Khargh HA, et al. Association of the human platelet antigens polymorphisms with platelet count in patients with COVID-19. Front Med. 2023; 10: 1265568.

DOI: https://doi.org/10.3389/fmed.2023.1265568

Saad S, Ahmed ST, Khatoon A, Ansari J, Mirza AJ. Unraveling coronary artery disease vulnerability in patients with ABO gene polymorphism: A Case-control study in Pakistan perspective. Pak Heart J. 2023; 56(3): 205-10.

DOI: https://doi.org/10.47144/phj.v56i3.2601

Dutra VD, Bub CB, Costa TH, Santos LD, Bastos EP, Aravechia MG, et al. Allele and haplotype frequencies of human platelet and leukocyte antigens in platelet donors. Einstein (Sao Paulo). 2019; 17(1): eAO4477.

DOI:https://doi.org/10.31744/einstein_journal/2019ao4 477

Ahmad N, Abbas S, Hafeez S, Ahmad N, Qayyum R, Mujahid S, et al. Prevalence of Congenital defects among consanguineous marriages in Pakistan. J Soc Prev Advocacy Res KEMU. 2023; 2(1): 1-11.

Available at: https://journalofspark.com/journal/index.php/JSpark/article/view/107

Hajar CG, Zefarina Z, Riffin NS, Mohammad TH, Hassan MN, Dafalla AM, et al. Human platelet antigen datasets for Malays, Chinese, and Indians in Peninsular Malaysia. Ann Lab Med. 2020; 40(6): 493-9.

DOI: https://doi.org/10.3343/alm.2020.40.6.493

Wenah-Emmanuel JE, Eze EM, Nwachuku EO, Wenah E, Jeremiah ZA. Assessment of gene frequencies of human platelet alloantigens in Rivers-State, Nigeria based on ABO/ Rhesus Blood Groups Distribution. Int Blood Res Rev. 2021; 12(3): 23-31. DOI: https://doi.org/10.9734/ibrr/2021/v12i330152

Kulkarni B, Mohanty D, Ghosh K. Frequency distribution of human platelet antigens in the Indian population. Transfus Med. 2005; 15(2):119-24. DOI: https://doi.org/10.1111/j.0958-7578.2005. 00 561.x

Garraud O, Chiaroni J. An overview of red blood cell and platelet alloimmunisation in transfusion. Transfus Clin Biol. 2022; 29(4): 297-306. DOI: https://doi.org/10.1016/j.tracli.2022.08.140

Elkobani H, Elbager S, Bayoumi MA. RBC alloimmunization in Sudanese multi-transfused patients. J Biosci App Res. 2020; 6(1): 30-7. DOI: https://doi.org/10.21608/jbaar.2020.115765

Dai X, Liu C, Chen R, Jiang T, Zhang R, Feng C, et al. HPA1-29w genotyping and the foundation for the platelet apheresis registry in Jiangsu Province of China by MassARRAY Spectrometry. Transfus Med Hemother. 2024; 51 (5): 345-50. DOI: https://doi.org/10.1159/000535653

Downloads

Published

27-12-2024

How to Cite

1.
Aslam S, Salamat N, Nasiruddin, Yazdani S, Khan SA, Naeem A. Human platelet antigen genotyping of platelet donors at a transfusion center in northern Pakistan. Pak J Pathol [Internet]. 2024 Dec. 27 [cited 2026 Nov. 18];35(4):198-204. Available from: https://www.pakjpath.com/index.php/Pak-J-Pathol/article/view/860